Document:

exv10w2

 

Exhibit 10.2

POST-EMPLOYMENT
NON-DISCLOSURE, NON-COMPETITION

AND NON-SOLICITATION AGREEMENT

     This Post-Employment Non-Disclosure, Non-Competition and Non-Solicitation Agreement (this
“Agreement”) is made as of June 30, 2006, by and among Richard Fritschi
(“Fritschi”), Zimmer Holdings, Inc. (“Zimmer Holdings”), and Zimmer GmbH
(“Zimmer GmbH”), a subsidiary of Zimmer Holdings. Zimmer Holdings and Zimmer GmbH,
together with all of their subsidiaries and affiliates worldwide, are sometimes collectively
referred to herein as “Zimmer”.

Recitals

     A. Fritschi has been an employee of Zimmer GmbH, most recently serving as President, Zimmer
Europe and Australasia. Zimmer GmbH and Fritschi are parties to the following agreements: (i)
Employment Contract, executed on or about September 10, 2004 (the “Employment Contract”),
and (ii) Confidentiality, Non-Competition and Non-Solicitation Employment Agreement, executed on or
about October 18, 2004 (the “Existing Non-Compete Agreement”). Additionally, Zimmer
Holdings and Fritschi are parties to three separate stock option award agreements, one of which was
executed in January 2004, and the other two of which were executed in January 2005 (collectively,
the “Stock Option Agreements”).

     B. On December 2, 2005, Zimmer GmbH notified Fritschi that it was exercising its right to
terminate his employment following the six-month notice period required by the Employment Contract.
Zimmer GmbH placed Fritschi on immediate garden leave (Freistellung) and notified him that the
effective date of the termination will be June 30, 2006 (the “Termination Effective Date”).

     C. On even date herewith, Fritschi, Zimmer Holdings and Zimmer GmbH entered into a Separation
Agreement (the “Separation Agreement”). As contemplated by Section 5 of the Separation Agreement,
the parties mutually desire to enter into this Agreement.

Agreement

     NOW, THEREFORE, in consideration of the foregoing recitals, the promises contained herein and
in the Separation Agreement, and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, Fritschi and Zimmer agree as follows:

     1. Recitals. The recitals set forth above are incorporated into and are a part of
this Agreement.

     2. Acknowledgements. Fritschi acknowledges that Zimmer is engaged in the highly
competitive business of the development, manufacture, distribution and sale of orthopaedic-medical,
oral-rehabilitation, and/or spine or trauma devices, products, and services

 

 

throughout the world. Fritschi acknowledges that, during his employment with Zimmer, he had
responsibility for Zimmer’s competitive position and financial viability throughout the world and
had access to Confidential Information (as hereinafter defined) relating to all aspects of running
Zimmer’s business. Further, Fritschi acknowledges that during the course of his employment with
Zimmer, he: (a) was given access to Confidential Information (as hereinafter defined); (b)
participated in the development and/or usage of inventions, products, concepts, methods, or
technologies that are related to Zimmer’s business; (c) was given specialized, proprietary training
relating to Zimmer’s products, processes, and Confidential Information; and/or (d) was given access
to Zimmer’s customers and other business relationships.

     3. Non-Disclosure of Confidential Information. Fritschi acknowledges that
Confidential Information is a valuable, special and unique asset of Zimmer and agrees to the
following:

(A) Confidential Information Defined. “Confidential Information” includes,
without limitation, any and all of Zimmer’s Trade Secrets (as defined by local law
and/or the law of the State of Indiana), Inventions (as defined herein),
confidential and proprietary information and all other information and data of
Zimmer that is not generally known to the public or other third parties, who could
derive economic value from its use or disclosure. Confidential Information
includes, without limitation, the following: (i) marketing, sales, and advertising
information, such as lists of actual or potential customers; customer-preference
data; marketing and sales techniques, strategies, efforts, and data; merchandising
systems and plans; confidential customer information including identification of
purchasing personnel, account status, needs and ability to pay; business plans;
product development and delivery schedules; market research and forecasts; marketing
and advertising plans, techniques, and budgets; overall pricing strategies; specific
advertising programs and strategies utilized, and the success or lack of success of
those programs and strategies; (ii) organizational information, such as personnel
and salary data; merger, acquisition and expansion information; information
concerning methods of operation; divestiture information; and competitive
information pertaining to Zimmer’s distributors; (iii) financial information such as
product costs; supplier information; overhead costs; profit margins; banking and
financing information; and pricing-policy practices; (iv) technical information,
such as product specifications, compounds, formulas, improvements, discoveries,
developments, designs, inventions, techniques, new products and surgical-training
methods; (v) information disclosed to Fritschi as part of any specialized,
proprietary training process; (vi) information of third parties provided to Fritschi
subject to non-disclosure restrictions; and (vii) any work product created by
Fritschi in rendering services for Zimmer.

(B) Non-Disclosure of Confidential Information. Fritschi agrees that he
will not disclose, transfer or use (or seek to induce others to disclose, transfer
or use) any Zimmer Confidential Information for any purpose.

(C) Protection of Confidential Information. Fritschi will notify Zimmer in

2

 

writing of any circumstances that may constitute unauthorized disclosure, transfer
or use of Confidential Information. Fritschi will use best efforts to protect
Confidential Information from unauthorized disclosure, transfer or use.

     4. Ownership of Confidential Information and Inventions.

(A) Invention Defined. “Invention” includes, without limitation, ideas,
programs, processes, systems, intellectual property, works of authorship,
copyrightable materials, discoveries, and improvements of which Fritschi conceived,
alone or in conjunction with others, during his employment with Zimmer or within six
(6) months after the Termination Effective Date and that relate to Zimmer’s present
or future business. An Invention is covered by this Agreement regardless of whether
(i) Fritschi conceived of the Invention in the scope or outside the scope of his
employment with Zimmer; and/or (ii) the Invention is patentable.

(B) Ownership of Confidential Information and Inventions. Confidential
Information and Inventions are solely the property of Zimmer. Fritschi agrees that
he does not have any right, title or interest in any of the Confidential Information
or Inventions. Fritschi may be recognized as the inventor of an Invention without
retaining any other rights associated therewith.

     5. Non-Competition Covenants. Fritschi acknowledges that the Existing Non-Compete
Agreement shall continue to be in full force and effect until the Termination Effective Date, and
that Zimmer may continue to enforce its rights and remedies under the Existing Non-Compete
Agreement subsequent to the Termination Effective Date for any violations which occurred on or
before June 30, 2006. Fritschi and Zimmer acknowledge and agree that the following
post-employment, non-competition covenants are reasonable and necessary to protect the legitimate
interests of Zimmer, including, without limitation, the protection of Confidential Information and
Inventions. Fritschi further acknowledges and agrees that such covenants are an essential part of,
and consideration for, Zimmer’s promises contained in the Separation Agreement and this Agreement.
Commencing as of July 1, 2006, Fritschi agrees to, and covenants to comply with, each of the
following separate and divisible restrictions:

(A) Definitions.

1. “Competing Product” includes any reconstructive orthopaedic, spine and/or
trauma device, product, or service, including any new product formulation,
product modification, and/or product improvement (a) that resembles or
competes with a device, product or service Zimmer researched, developed,
manufactured, marketed, distributed, or sold during the term of Fritschi’s
employment with Zimmer leading up to the Termination Effective Date and (b)
with which Fritschi worked in the course of his employment with Zimmer or
about which Fritschi obtained Confidential Information in the course of his
employment with Zimmer.

3

 

2. “Competing Organization” includes: (a) any organization, or any division
or unit of an organization, that researches, develops, manufactures,
markets, distributes or sells any Competing Product; or (b) any
organization, or any division or unit of an organization, that plans to
research, develop, manufacture, market, distribute or sell any Competing
Product.

3. “Diversified Competing Organization” includes any Competing Organization
that controls or is under common control with entities that conduct business
in an industry other than the orthopaedic, spine-implant or trauma products
industries.

4. “Same or Similar Capacity” includes: (a) duties, responsibilities, or
functions Fritschi is expected to perform or does perform for a Competing
Organization which are the same as, or similar to, his duties,
responsibilities or functions during the last two years of his employment
with Zimmer; b) any executive or managerial capacity; or c) any other
capacity in which Fritschi’s knowledge of Zimmer Confidential Information or
Inventions would constitute a competitive disadvantage to Zimmer if used on
behalf of the Competitive Organization.

5. “Restricted Geographic Area” includes the countries of the European
Community and the European Free Trade Association (EFTA), Central and
Eastern European countries, the Mediterranean countries, and the countries
in the Middle East and Africa.

6. “Non-Competition Period” begins on July 1, 2006 and continues for a
period of twenty-four (24) months, expiring on June 30, 2008, unless
otherwise extended by Fritschi’s breach of this Agreement. The
Non-Competition Period shall not expire during any period in which Fritschi
is in violation of any of the restrictive covenants set forth herein, and
all restrictions shall automatically be extended by the period Fritschi was
in violation of any such restrictions.

7. “Customer” includes, without limitation, any distributor, health care
provider, health care dealer, hospital, hospital system, university
practitioner, surgeon, health care purchasing organization, or surgical
group with which Fritschi had a business relationship on behalf of Zimmer
during the last two years of his employment with Zimmer and that (a)
purchased, marketed or distributed any competing products during the last
two years of Fritschi’s Zimmer employment; (b) participated in or influenced
the purchasing decisions of any Customer of Zimmer; or (c) used Zimmer’s
devices, products or services purchased by a Customer of Zimmer.

8. “Potential Customer” includes, without limitation, any distributor,

4

 

health care provider, health care dealer, hospital, hospital system,
university practitioner, surgeon, health care purchasing organization, or
surgical group which Fritschi identified, marketed to or held discussions
with regarding the research, development, manufacture, distribution or sale
of any Competing Products during the last two years of Fritschi’s employment
with Zimmer.

(B) Restrictive Covenants. During the Non-Competition Period, Fritschi agrees
to be bound by each of the following independent and divisible restrictions:

1. Fritschi will not seek or obtain employment with, work for, consult with,
or lend assistance to any Competing Organization in a Same or Similar
Capacity in the Restricted Geographic Area.

2. Fritschi will not seek or obtain employment with, work for, consult with,
or lend assistance to any Competing Organization in any capacity if it is
likely that as part of such capacity, Fritschi would inevitably use or
disclose any of Zimmer’s Confidential Information or Inventions.

3. Fritschi will not seek or obtain employment with, work for, consult with,
or lend assistance to any Competing Organization in any capacity involving
any Competing Product.

4. Fritschi may accept employment with, work for, consult with, or lend
assistance to any Diversified Competing Organization provided that (a) the
division or unit of the Diversified Competing Organization with which
Fritschi will be affiliated is not a Competing Organization; (b) Fritschi’s
affiliation with the Diversified Competing Organization does not involve any
Competing Product; (c) Fritschi provides Zimmer with a written description
of his anticipated activities on behalf of the Diversified Competing
Organization; (d) Fritschi ‘s affiliation with the Diversified Competing
Organization would not likely cause Fritschi to inevitably use and/or
disclose any Zimmer Confidential Information; and (e) Fritschi ‘s
affiliation with the Diversified Competing Organization does not constitute
a competitive disadvantage to Zimmer.

5. Fritschi will not seek or obtain employment with, work for, consult with,
or lend assistance to any Customers or Potential Customers in the Restricted
Geographic Area in a competitive capacity in which his knowledge of Zimmer’s
Confidential Information would inevitably be used to Zimmer’s competitive
disadvantage or for a competitive purpose.

6. Fritschi will not solicit, attempt to solicit, or engage in discussions
or other communications with any Customer or Potential Customer with the
purpose or intent of promoting, marketing, selling or obtaining orders for
any Competing Product.

5

 

7. Fritschi will not interfere adversely with past, present or prospective
business relationships between Zimmer and any of its Customers, Potential
Customers, suppliers, distributors, agents, sales representatives,
employees, independent contractors or other persons or entities with which
Zimmer conducts business.

8. Fritschi will not solicit for employment, advise or recommend to any
other person or entity that such person or entity solicit for employment,
any individual employed by Zimmer during the last two years of Fritschi’s
employment with Zimmer, or otherwise induce or entice any such employee to
leave employment with Zimmer to work for, consult with, or lend assistance
to any Competing Organization.

9. Fritschi agrees to refrain from making any disparaging or derogatory
statements about Zimmer, its products, or its past, present and future
officers, directors, employees, attorneys and agents. Disparaging or
derogatory statements include, but are not limited to, negative statements
regarding Zimmer’s business or other practices.

10. Fritschi agrees that the divisible covenants contained in this Agreement
prohibit him from engaging in the restricted activities whether on his own
behalf or on behalf of, or for the benefit of, any other person or entity.

     6. Reasonableness of Terms. Fritschi acknowledges that the restrictive covenants
contained in this Agreement are necessary to protect Zimmer’s legitimate interests in Confidential
Information, Inventions and goodwill. Fritschi further acknowledges that, in light of Zimmer’s
obligations under the Separation Agreement and otherwise, the restrictive covenants set forth in
this Agreement will not pose any hardship on Fritschi and that he will reasonably be able to earn
an equivalent livelihood without violating any provision of this Agreement.

     7. Severability and Modification of Restrictions. The covenants and restrictions in
this Agreement are separate and divisible, and to the extent any clause, portion, or section of
this Agreement is determined to be unenforceable or invalid for any reason, Zimmer and Fritschi
acknowledge and agree that such unenforceability or invalidity shall not affect the enforceability
or validity of the remainder of the Agreement. If any particular covenant, provision or clause of
this Agreement is determined to be unreasonable or unenforceable for any reason, including, without
limitation, the temporal duration, scope of prohibited activity, and/or geographic area covered by
any non-competition, non-solicitation, non-disparagement or non-disclosure covenant, provision, or
clause, Zimmer and Fritschi acknowledge and agree that such covenant, provision, or clause shall
automatically be deemed reformed such that the contested covenant, provision, or clause will have
the closest effect permitted by applicable law to the original form and shall be given effect and
enforced as so reformed to whatever extent would be reasonable and enforceable under applicable
law. The parties agree that any court interpreting this Agreement shall have the authority, if
necessary, to reform the Agreement to render it

6

 

enforceable under applicable law.

     8. Remedies.

     (A) In addition to all other relief to which Zimmer may be entitled, as provided in the
Separation Agreement, if Fritschi breaches the terms of this Agreement, as determined by a
competent court of law, Fritschi and Zimmer agree that Fritschi shall no longer receive the
payments described under Section 5(b) of the Separation Agreement and Fritschi shall refund to
Zimmer any sums previously paid by Zimmer to Fritschi under said Section 5(b).

     (B) Fritschi acknowledges that a breach or threatened breach by him of this Agreement will
give rise to irreparable injury to Zimmer and that money damages will not be adequate relief for
such injury. However, for each violation of the covenants set forth in this Agreement, as
determined by a competent court of law, Fritschi shall pay Zimmer an amount equal to one times his
Zimmer 2005 annual base salary and target bonus amount as liquidated damages in addition to any
other damages as may be incurred by Zimmer. The payment of liquidated damages shall not operate as
a waiver of Zimmer’s rights or Fritschi’s obligations under this Agreement. Accordingly, Fritschi
agrees that Zimmer shall be entitled to obtain injunctive relief, including, but not limited to,
temporary restraining orders, preliminary injunctions, or permanent injunctions, without having to
post any bond or other security, to restrain or prohibit such breach or threatened breach, in
addition to any other legal remedies that may be available.

     (C) In the event Fritschi breaches the terms of this Agreement, Fritschi shall disgorge to
Zimmer any and all gains realized from stock option exercises relating to the Stock Option
Agreements.

     (D) Zimmer shall be entitled to recover from Fritschi all litigation costs and attorneys’
fees incurred by Zimmer in any action or proceeding relating to this Agreement, the Existing
Non-Compete Agreement and/or the Separation Agreement, in which Zimmer prevails, including, but not
limited to, any action or proceeding in which Zimmer seeks enforcement of this Agreement or seeks
relief from Fritschi’s violation of this Agreement.

     9. Governing Law and Jurisdiction. This Agreement, including the jurisdiction clause,
shall be governed by, interpreted and construed in accordance with the substantive laws of
Switzerland. Exclusive jurisdiction for all disputes arising out of or in connection with this
Agreement shall be with the ordinary courts of Zurich 1.

     10. Successors. This Agreement shall inure to the benefit of, and may be enforced by,
any and all successors of Zimmer, including, without limitation, by asset assignment, stock sale,
merger, consolidation or other corporate reorganization, and shall be binding on Fritschi and his
executors, administrators, personal representatives or other successors-in-interest.

     11. Modification. This Agreement may not be amended, supplemented or modified except
by a written document signed by Fritschi and a duly-authorized officer of Zimmer Holdings and
Zimmer GmbH.

     12. No Waiver. The failure of Zimmer to insist upon performance of any of the

7

 

provisions of this Agreement or to pursue its rights hereunder shall not be construed as a
waiver of any such provisions or the relinquishment of any such rights. All waivers must be in
writing.

     13. Counterparts. This Agreement may be executed in counterparts, each of which shall
be deemed an original, but each of which when taken together will constitute one and the same
agreement.

     14. Entire Agreement. This Agreement, together with the Separation Agreement,
constitutes the entire agreement of the parties with respect to the subjects specifically addressed
herein, and supersedes any prior agreements, understandings, or representations, oral or written,
on the subjects addressed herein. Notwithstanding the foregoing, Zimmer may continue to enforce
its rights and remedies under and pursuant to the Existing Non-Compete Agreement.

     Fritschi’s signature below indicates that he has been given ample time to consider the entire
Agreement, he has read the entire Agreement, he understands what he is signing, and he is signing
it voluntarily. Fritschi acknowledges that Zimmer advised him to consult with an attorney prior to
signing the Agreement.

	 	 	 	 	 
	 	 	 
	 	                                                         /s/ RICHARD FRITSCHI
 	 
	 	RICHARD FRITSCHI 	 
	 	 	 
	 
	 	ZIMMER HOLDINGS, INC.

 	 
	 	By:  	/s/ J. RAYMOND ELLIOTT
 	 
	 	 	Name:  	J. Raymond Elliott 	 
	 	 	Title:  	Chairman, President & CEO 	 
	 
	 	ZIMMER GmbH

 	 
	 	By:  	/s/ ROLAND DIGGELMANN
 	 
	 	 	Name:  	Roland Diggelmann 	 
	 	 	Title:  	Sr. VP, Sales & Distribution, Europe & MEA 	 
	 

8Promissory Note

 

Exhibit 10.2

PROMISSORY NOTE

			
	$200,000
	 	As of June 12, 2006

Coral Gables, FL

     MBF HEALTHCARE ACQUISITION CORP. (the “Maker”) promises to pay to the order of MBF HEALTHCARE
PARTNERS, L.P. (the “Payee”) the principal sum of Two Hundred Thousand Dollars ($200,000) in lawful
money of the United States of America together with interest on the unpaid principal balance of
this Promissory Note (this “Note”), on the terms and conditions described below.

     1. Principal. The principal balance of this Note, along with all accrued interest, shall be
payable on the earlier of (a) June 12, 2007 and (b) the date on which Maker consummates an initial
public offering of its securities under the Securities Act of 1933, as amended.

     2. Interest. Interest shall accrue at the rate of 5.0% per year on the unpaid principal
balance of this Note. Interest shall be computed on the basis of the actual number of days elapsed
and a year of 365 days.

     3. Application of Payments. All payments shall be applied first to payment in full of any
costs incurred in the collection of any sum due under this Note, including (without limitation)
reasonable attorneys’ fees, then to the reduction of the unpaid principal and interest balance of
this Note.

     4. Events of Default. Each of the following shall constitute an event of default (“Event of
Default”) under this Note:

          (a) Failure to Make Required Payments. Failure by Maker to pay the principal and accrued
interest of this Note within five (5) business days following the date when due.

          (b) Voluntary Bankruptcy, Etc. The commencement by Maker of a voluntary case under the Federal
Bankruptcy Code, as now constituted or hereafter amended, or any other applicable federal or state
bankruptcy, insolvency, reorganization, rehabilitation or other similar law, or the consent by it
to the appointment of or taking possession by a receiver, liquidator, assignee, trustee, custodian,
sequestrator (or other similar official) of Maker or for any substantial part of its property, or
the making by it of any assignment for the benefit of creditors, or the failure of Maker generally
to pay its debts as such debts become due, or the taking of corporate action by Maker in
furtherance of any of the foregoing.

          (c) Involuntary Bankruptcy, Etc. The entry of a decree or order for relief by a court having
jurisdiction in the premises in respect of maker in an involuntary case under the Federal
Bankruptcy Code, as now or hereafter constituted, or any other applicable federal or state
bankruptcy, insolvency or other similar law, or appointing a receiver, liquidator, assignee,
custodian, trustee, sequestrator (or similar official) of Maker or for any substantial part of its
property, or ordering the winding-up or liquidation of its affairs, and the continuance of any such
decree or order unstayed and in effect for a period of sixty (60) consecutive days.

 

 

     5. Remedies.

          (a) Upon the occurrence of an Event of Default specified in Section 4(a) hereof, Payee may, by
written notice to Maker, declare this Note to be immediately due and payable, whereupon the unpaid
principal amount of this Note, along with accrued interest and all other amounts payable hereunder,
shall become immediately due and payable without presentment, demand, protest or other notice of
any kind, all of which are hereby expressly waived, anything contained herein or in the documents
evidencing the same to the contrary notwithstanding.

          (b) Upon the occurrence of an Event of Default specified in either Section 4(b) or Section
4(c) hereof, the unpaid principal balance of this Note, along with accrued interest and all other
amounts payable hereunder, shall automatically and immediately become due and payable, in all cases
without any action on the part of Payee, including presentment, demand, protest or other notice of
any kind, all of which are hereby expressly waived.

     6. Waivers. Maker and all endorsers and guarantors of, and sureties for, this Note waive
presentment for payment, demand, notice of dishonor, protest, and notice of protest with regard to
the Note, all errors, defects and imperfections in any proceedings instituted by Payee under the
terms of this Note, and all benefits that might accrue to Maker by virtue of any present or future
laws exempting any property, real or personal, or any part of the proceeds arising from any sale of
any such property, from attachment, levy or sale under execution, or providing for any stay of
execution, exemption from civil process, or extension of time for payment; and Maker agrees that
any real estate that may be levied upon pursuant to a judgment obtained by virtue hereof, on any
writ of execution issued hereon, may be sold upon any such writ in whole or in part in any order
desired by Payee.

     7. Unconditional Liability. Maker hereby waives all notices in connection with the delivery,
acceptance, performance, default, or enforcement of the payment of this Note, and agrees that its
liability shall be unconditional, without regard to the liability of any other party, and shall not
be affected in any manner by any indulgence, extension of time, renewal, waiver or modification
granted or consented to by Payee, and consents to any and all extensions of time, renewals,
waivers, or modifications that may be granted by Payee with respect to the payment or other
provisions of this Note, and agrees that additional makers, endorsers, guarantors, or sureties may
become parties hereto without notice to it or affecting its liability hereunder.

     8. Notices. Any notice called for hereunder shall be deemed properly given if in writing and
(i) sent by certified mail, return receipt requested, (ii) personally delivered, (iii) dispatched
by any form of private or governmental express mail or delivery service providing receipted
delivery, (iv) sent by confirmed telefacsimile or (v) sent by confirmed e-mail, to the following
addresses or to such other address as either party may designate by notice in accordance with this
Section:

     If to Maker:

MBF Healthcare Acquisition Corp.

121 Alhambra Plaza, Suite 1100

Coral Gables, FL 33134

2

 

     If to Payee:

MBF Healthcare Partners, L.P.

121 Alhambra Plaza, Suite 1100

Coral Gables, FL 33134

Notice shall be deemed given on the earlier of (i) actual receipt by the receiving party, (ii) the
date shown on the confirmed telefacsimile transmission confirmation, (iii) the date on which an
e-mail transmission was received by the receiving party’s on-line access provider (iv) the date
reflected on a signed delivery receipt, or (v) two (2) Business Days following tender of delivery
or dispatch by express mail or delivery service.

     9. Governing Law; Construction. This Note, the legal relations between the Maker and Payee and
the adjudication and the enforcement hereof shall be governed by and construed in accordance with
the laws of the State of Florida applicable to contracts executed in and to be performed in that
state, without regard to the conflicts of law provisions thereof to the extent such principles or
rules would require or permit the application of the laws of another jurisdiction.

     10. Severability. Any provision contained in this Note which is prohibited or unenforceable in
any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition
or unenforceability without invalidating the remaining provisions hereof, and any such prohibition
or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision
in any other jurisdiction.

     IN WITNESS WHEREOF, Maker, intending to be legally bound hereby, has caused this Note to be
duly executed the day and year first above written.

	 	 	 	 	 
	 	MBF HEALTHCARE ACQUISITION CORP.

 	 
	 	By:  	/s/Marcio Cabrera
 	 
	 	 	Name:  	Marcio Cabrera 	 
	 	 	Title:  	Chief Financial Officer 	 
	 

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00106-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00106-of-00352.parquet"}]]